Cytrellis® Biosystems Reaches New Milestone with 100th ellacor® System Delivered

20 March 2023 | Monday | News


Innovative Micro-Coring® Technology Continues to Build Momentum and Expand Availability

Cytrellis Biosystems, a pioneer in novel medical aesthetic solutions, celebrates the delivery of the 100th ellacor system with Micro-Coring Technology. This milestone, and continued adoption of ellacor into prestigious practices, further exemplifies physician confidence in this novel, non-surgical approach to scarless skin removal.

"With ellacor, we are developing a completely new vertical in the aesthetics space and are highly encouraged to see Dermatologists & Plastic Surgeons embrace our patented dermal Micro-Coring Technology nationwide. Accelerated physician adoption reinforces our position that there is a substantial treatment gap between energy based aesthetic devices and facelifts where ellacor can now be utilized," says Jason Richey, President & CEO of Cytrellis Biosystems. "As a first to market technology, we prioritize education and training to maximize the value that ellacor can deliver to our patients and physician practices. This is just the beginning as we work towards shaping the future of aesthetic possibilities."

Since becoming FDA-cleared, ellacor with patented Micro-Coring Technology has become the sought-after modality in the aesthetic space for the removal of sagging and unwanted skin. The Micro-Coring procedure precisely removes up to 12,000 cores of tissue without scarring, resulting in the reduction of wrinkles in the mid to lower face.

"The decision to add another system into the practice is never an easy one, but ellacor stood out to me as it is truly in a class of its own with its ability to remove sagging skin without surgery," says Michael Abrouk, M.D., dermatologist at Skin Associates of South Florida. "I had an extremely positive clinical experience working with ellacor during my specialized fellowship training in Lasers and Cosmetic Dermatologic Surgery at the Harvard and Massachusetts General Hospital in Boston. This hands-on experience, combined with the use of ellacor by respected peers, led our team to adopt the system into our own practice. We are incredibly excited to now offer the ellacor Micro-Coring procedure to our patients to fill the gap between minimally invasive treatments and surgery, and to continue to remain at the cutting edge of technological innovation."

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close